Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2025 12:35 ET | Source: Tevogen Bio Inc

Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress

WARREN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), in ongoing community, industry, and academic engagements, has continued to...
October 22, 2025 10:44 ET | Source: Research and Markets

T-Cell Malignancies Pipeline Research Report 2025: Market Opportunities with Over 75 Companies and 80+ Drugs, Exploring Novel Treatments Like CAR-T Therapies and Targeted Therapies

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "T-Cell Malignancies - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report offers in-depth analysis of over 75...
October 14, 2025 08:00 ET | Source: Tr1X, Inc.

Tr1X Announces FDA Clearance of IND Application for TRX319, a First-in-Class Allogeneic CAR-Tr1 Treg Cell Therapy for Progressive Multiple Sclerosis, and $50 Million in Additional Financing

Tr1X announced the FDA has cleared its IND application for TRX319 in progressive multiple sclerosis and a $50M financing that extends its runway into 2027.
October 02, 2025 04:17 ET | Source: Research and Markets

Clinical Trials Boost CAR T-Cell Therapy as Efficacy Sparks Major Approvals for Non-Hodgkin's Lymphoma

Dublin, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The "CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market - A Global and Regional Analysis: Focus on Indication, Therapy, and Region - Analysis and...
September 25, 2025 07:01 ET | Source: Research and Markets

Gene Therapy: Global and Regional Market Forecasts (2025-2030) by Therapy Type, Vector Type, Technique Type and Disease Type

Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering. The global gene therapy market is projected...
September 05, 2025 10:39 ET | Source: Research and Markets

$5.1 Bn Chimeric Antigen Receptor (CAR) T-cell Therapy Market Analysis by Indication, Cell Source, Generation, Line Of Therapy, Target Antigen, End User - Global Forecast to 2030

Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The "CAR T-cell Therapy Market by Indication (Leukemia, Multiple Myeloma, Non Hodgkin Lymphoma), Cell Source (Allogeneic, Autologous), Generation, Line Of...
August 19, 2025 15:40 ET | Source: Tevogen Bio Inc

REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts

Agreement for Up to $50 Million in Financing. Includes $36 million line of credit and potential $14 million private placement.
August 14, 2025 07:00 ET | Source: EvolveImmune

EvolveImmune Therapeutics Announces FDA Clearance of Investigational New Drug Application for EVOLVE104, a Novel Trispecific T Cell Engager with Integrated CD2 Costimulation

First Program from EVOLVE T-Cell Engager Platform to Advance into Clinical Development Phase 1 Clinical Trial of EVOLVE104 to be Initiated in 2025 BRANFORD, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE)...
July 24, 2025 04:20 ET | Source: Research and Markets

CAR T-Cell Therapy Market Trends and Forecasts, 2021-2024 & 2025-2033 | Focus on Yescarta, Tecartus, Kymriah, Breyanzi, Abecma, Carvykti, and Carteyva

Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "CAR T-Cell Therapy Market Size, Growth, Share, Trends and Forecasts 2025-2033" report has been added to ResearchAndMarkets.com's offering. The...
June 27, 2025 08:03 ET | Source: Research and Markets

Global Gamma Delta T Cell Cancer Therapy Market Shaped by Over 25 Clinical Trials

Dublin, June 27, 2025 (GLOBE NEWSWIRE) -- The "Gamma Delta T Cell Cancer Therapy Market Trends, Technology Platforms & Clinical Trials Outlook 2031" report has been added to ...